Medical
Quantum BioPharma Partners with Massachusetts General Hospital to Advance Imaging for Multiple Sclerosis
Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company focused on developing innovative solutions for neurodegenerative and metabolic disorders, has announced a collaborative clinical study with...
Endo’s Mixed Reality Simulator Reshapes Pharmaceutical Training
In a groundbreaking move, Endo, Inc. (OTCQX: NDOI) has launched the Spatial Computing Injection Simulator, marking a significant leap in medical education technology. This innovative...
Promising Brain Cancer Drug Shows Mixed Results in Late-Stage Trial
A novel brain cancer treatment developed by CNS Pharmaceuticals (NASDAQ: CNSP) has shown mixed results in a late-stage clinical trial. The drug, Berubicin, did not...
Medexus Pharmaceuticals Returns U.S. Gleolan Rights to NX Development Corp.
Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF) has finalized an agreement to transfer U.S. commercialization rights for Gleolan® back to NX Development Corp. (NXDC). This decision...
Pioneering Medical Imaging Technology Debuts in Tennessee Hospital
In a significant advancement for surgical oncology, Covenant Health Fort Sanders Regional has become the first hospital in Tennessee to adopt a cutting-edge imaging technology...
Arcuro Medical Secures FDA Clearance for Innovative Rotator Cuff Repair System
In a significant development for the medical device industry, Arcuro Medical Ltd., a portfolio company of The Trendlines Group (SGX: 42T, OTCQX: TRNLY) has announced...
Can Hemp Save California? Natural Building Advocates Push for Code Reform
California homeowners are facing a crisis. Wildfires are increasing in frequency and intensity, and the reliance on conventional, often toxic, building materials is exacerbating the...
Endo Pharmaceuticals Launches Patient-Centric Campaign for Xiaflex
Endo Pharmaceuticals (OTCQX: NDOI) is shifting its marketing strategy for Xiaflex, the only FDA-approved nonsurgical treatment for Dupuytren’s contracture, with the launch of a new...
Breakthrough COVID-19 Vaccine Gains European Approval
In a significant development for the biotechnology industry, the European Commission has authorized the marketing of KOSTAIVE, the first self-amplifying mRNA (sa-mRNA) COVID-19 vaccine. This...
CSL Behring’s Hemophilia B Gene Therapy, HEMGENIX®, Shows Sustained Efficacy in Long-Term Study
CSL Behring (ASX: CSL, OTCQX: CSLLY) has released four-year data from its Phase 3 HOPE-B trial, demonstrating the long-term efficacy and safety of its gene...
